ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 107

Expanded Peripheral T Helper Cells Characterize the Early Rheumatoid Arthritis Synovium

William Murray-Brown1, Yanxia Guo 2, Mihir Wechalekar 1, Helen Weedon 1, Malcolm Smith 1, Susanna Proudman 3, Navin Rao 4, Sunil Nagpal 4 and Mihir Wechalekar 1, 1Flinders University, Adelaide, Australia, 2Janssen Research, Spring House, 3Adelaide University, Adelaide, Australia, 4Janssen R&D, Spring House, PA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: adaptive immunity, Early Rheumatoid Arthritis, Tph and Synovial Immune Biology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Programmed cell death protein 1 (PD-1) expressing T-cells are implicated in the pathogenesis of autoimmune inflammatory diseases such as rheumatoid arthritis (RA). In secondary lymphoid organs, CXCR5+ T follicular helper (TFH) cells secrete IL-21 and provide co-stimulatory signals to germinal centre (GC) B cells, allowing for affinity maturation of antibody responses. Recently a new subset of CXCR5- T-cells, termed T peripheral helper (TPH) cells driving B cell differentiation, have been identified in ectopic lymphoid structures in established RA synovial tissue (ST). Critically, it remains unknown whether TPH cells accumulate in treatment-naïve early RA prior to fully established disease. We aimed to identify TPH cells in treatment naïve early RA patients using flow cytometry (FACS) and multi-parameter immunofluorescence (IF) microscopy from ST and matched peripheral blood mononuclear cells (PBMCs).

Methods: FACS: Fresh dissociated ST (n=4), and PBMCs (n=7) single cell suspensions were stained with Zombie UV®, CD45RO, PD1, CD3, ICOS, CD8, CD4, CD20, CXCR5, TIGIT and CD38 and analysed using FlowJo 10.5.2.

Histology: 4????m thick RA ST sections were prepared for Opal™ multispectral IF. Primary antibodies for CD45RO, CD20, PD-1 and CXCR5 were sequentially stained, each followed by HRP amplification and specific Opal™ reactive fluorophores. DAPI nuclear staining was performed prior to image acquisition on the Perkin Elmer Vectra 3.0 imaging system. Images were processed and analyzed using InForm®, a machine learning software package, where the tissue segmentation and TPH and TFH cells quantification was performed.

Results: ST FACS demonstrated T cell infiltration in ST with differential expression of PD-1, CD45RO, ICOS, TIGIT and CD38 (Figure 1A). We observed a higher frequency of PD1hi CXCR5- TPH in RA ST and PBMCs vs. controls (Figure 1B-D). Importantly, no significant difference in TFH frequency was observed in RA and controls. Furthermore, IF identified a 10-fold increase of TPH cells in early RA ST follicular and diffuse regions and identified TPH adjacent to GC B cells (Figure 1E-I).

Conclusion: In this study, we demonstrate, for the first time, the presence and potential role of TPH cells in early RA, with TPH accumulation and close interaction with GC B-cells, potentially contributing to disease pathogenesis and progression. TPH cells may be a novel immune cell target to therapeutic interception of disease progression and warrant further study in early RA.


Murray-Brown et al., Fig. 1


Disclosure: W. Murray-Brown, None; Y. Guo, Johnson & Johnson, 1, 3, 4; M. Wechalekar, None; H. Weedon, None; M. Smith, None; S. Proudman, None; N. Rao, Janssen Research & Development, 3, Johnson & Johnson, 1, 3, 4; S. Nagpal, Janssen Research & Development, 3, Janssen Research, Johnson&Johnson, 1, 3, 4, Johnson & Johnson, 1, 4; M. Wechalekar, Johnson & Johnson, 2.

To cite this abstract in AMA style:

Murray-Brown W, Guo Y, Wechalekar M, Weedon H, Smith M, Proudman S, Rao N, Nagpal S, Wechalekar M. Expanded Peripheral T Helper Cells Characterize the Early Rheumatoid Arthritis Synovium [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/expanded-peripheral-t-helper-cells-characterize-the-early-rheumatoid-arthritis-synovium/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expanded-peripheral-t-helper-cells-characterize-the-early-rheumatoid-arthritis-synovium/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology